Wei Duan1,2, Li Zhang1,2, Shuangsheng Wu1,2, Chunna Ma1,2, Ying Sun1,2, Man Zhang1,2, Yi Zhang1,2, Xingxing Zhang1,2, Quanyi Wang1,2, Peng Yang1,2,3. 1. a Institute for Infectious Disease and Endemic Disease Control , Beijing Center for Disease Prevention and Control , Beijing , China. 2. b Institute for Infectious Disease and Endemic Disease Control , Beijing Research Center for Preventive Medicine , Beijing , China. 3. c School of Public Health, Capital Medical University , Beijing , China.
Abstract
BACKGROUND: Little is known about the vaccine effectiveness (VE) in attenuating the influenza-associated symptoms in children during the 2014-2015 influenza season in Beijing, China, in which there was a mismatch between the vaccine and circulating strain. METHODS: This study included 210 laboratory-confirmed influenza cases among children, who were enrolled in 2014, from November 1 to December 31. Standard demographic information and clinical symptoms were recorded. Influenza vaccination was confirmed via a vaccination registry. Univariate and multivariate analyses were used to estimate the odds of presenting with clinical symptoms among vaccinated and unvaccinated groups, adjusting for sex, age, area, BMI level, and chronic conditions. RESULTS: Among the 210 laboratory-confirmed influenza cases, 170 (81.0%) presented with fever ≥38°C. The other most common symptoms were cough (78.1%), sore throat (46.7%), nasal congestion/rhinorrhea (38.6%), headache (34.8%), fatigue (24.8%) and myalgia/arthralgia (16.2%). Approximately 9.0% (19/210) exhibited nausea/vomiting, and 2.4% (5/210) exhibited diarrhea/abdominal pain. Respiratory complications occurred in 5.7% (12/210) of the confirmed influenza cases. In 210 laboratory-confirmed cases, univariate and multivariate conducted after adjusted for the aforementioned characteristics suggested that the odds of fever ≥ 38°C were significantly reduced in vaccinated children (odds ratio [OR]: 0.42, 95% CI: 0.19-0.93; P = 0.033). CONCLUSIONS: Influenza vaccination may reduce the clinical symptoms of laboratory-confirmed influenza cases potentially even in the mismatching season.
BACKGROUND: Little is known about the vaccine effectiveness (VE) in attenuating the influenza-associated symptoms in children during the 2014-2015 influenza season in Beijing, China, in which there was a mismatch between the vaccine and circulating strain. METHODS: This study included 210 laboratory-confirmed influenza cases among children, who were enrolled in 2014, from November 1 to December 31. Standard demographic information and clinical symptoms were recorded. Influenza vaccination was confirmed via a vaccination registry. Univariate and multivariate analyses were used to estimate the odds of presenting with clinical symptoms among vaccinated and unvaccinated groups, adjusting for sex, age, area, BMI level, and chronic conditions. RESULTS: Among the 210 laboratory-confirmed influenza cases, 170 (81.0%) presented with fever ≥38°C. The other most common symptoms were cough (78.1%), sore throat (46.7%), nasal congestion/rhinorrhea (38.6%), headache (34.8%), fatigue (24.8%) and myalgia/arthralgia (16.2%). Approximately 9.0% (19/210) exhibited nausea/vomiting, and 2.4% (5/210) exhibited diarrhea/abdominal pain. Respiratory complications occurred in 5.7% (12/210) of the confirmed influenza cases. In 210 laboratory-confirmed cases, univariate and multivariate conducted after adjusted for the aforementioned characteristics suggested that the odds of fever ≥ 38°C were significantly reduced in vaccinated children (odds ratio [OR]: 0.42, 95% CI: 0.19-0.93; P = 0.033). CONCLUSIONS: Influenza vaccination may reduce the clinical symptoms of laboratory-confirmed influenza cases potentially even in the mismatching season.
Authors: Jill M Ferdinands; Lauren E W Olsho; Anna A Agan; Niranjan Bhat; Ryan M Sullivan; Mark Hall; Peter M Mourani; Mark Thompson; Adrienne G Randolph Journal: J Infect Dis Date: 2014-03-26 Impact factor: 5.226
Authors: Tammy A Santibanez; Peng-Jun Lu; Alissa O'Halloran; Ankita Meghani; Mark Grabowsky; James A Singleton Journal: Public Health Rep Date: 2014 Sep-Oct Impact factor: 2.792
Authors: Pedro A Piedra; Manjusha J Gaglani; Claudia A Kozinetz; Gayla Herschler; Mark Riggs; Melissa Griffith; Charles Fewlass; Matt Watts; Colin Hessel; Julie Cordova; W Paul Glezen Journal: Vaccine Date: 2005-02-18 Impact factor: 3.641
Authors: Cuc H Tran; Jonathan D Sugimoto; Juliet R C Pulliam; Kathleen A Ryan; Paul D Myers; Joan B Castleman; Randell Doty; Jackie Johnson; Jim Stringfellow; Nadia Kovacevich; Joe Brew; Lai Ling Cheung; Brad Caron; Gloria Lipori; Christopher A Harle; Charles Alexander; Yang Yang; Ira M Longini; M Elizabeth Halloran; J Glenn Morris; Parker A Small Journal: PLoS One Date: 2014-12-09 Impact factor: 3.240
Authors: Ting F Leung; Renee W Y Chan; Angela Kwok; Wendy C S Ho; Mars K P Tao; Kam L Hon; Frankie W T Cheng; Albert M Li; Paul K S Chan Journal: Influenza Other Respir Viruses Date: 2017-05-25 Impact factor: 4.380